查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1195538

3D 腹腔镜成像市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

3D Laparoscopy Imaging Market- Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 3D 腹腔镜成像市场在预测期内（2022 年至 2027 年）将以近 4.5% 的复合年增长率增长。

COVID-19 的爆发使 3D 腹腔镜手术重新成为人们关注的焦点，因为研究表明接受减肥手术的患者入院和重症监护病房 (ICU) 的风险较低 根据 2021 年 1 月发表在《肥胖及相关疾病外科》杂誌上的“既往代谢和减肥手术与肥胖患者冠状病毒病 (COVID-19) 的严重程度的关联”研究，克利夫兰诊所的研究作者委託进行的一项研究发现有代谢手术史的严重肥胖患者感染 SARS-CoV-2 的严重程度较轻，住院和入住 ICU 的风险较低，这导致了上述观察结果。没错。 预计这将增加对减肥手术的需求，进而对 3D 腹腔镜设备的需求产生积极影响。 此外，根据 Bhavid-19 的一项名为“COVID-19 大流行期间的腹腔镜胃肠手术”的研究，这是一项“单中心经验”。 Bhavin Patel 的“单中心体验” 2021 年 4 月 由于 COVID-19 时代，腹腔镜手术正在减少，由于病毒感染的风险，腹腔镜手术成为高风险手术。 因此，腹腔镜手术的下降可能会阻碍腹腔镜影像市场。 因此，市场在 COVID-19 时代受到了严重影响。

市场增长因素包括对 3D 成像技术的日益偏好和进步、肥胖的增加和对减肥手术的需求增加，以及对微创手术的需求增加。

是否应该将诊所从 2D 环境替换为 3D 环境，以便对腹腔镜新手进行有效培训？ A Critical Analysis of the Learning Curve for Basic Skills”（2022 年 1 月，Frontier in Surgery），一项简单的标准化测试表明，腹腔镜新手在 2D 和 3D 技术之间经历了显着的执行时间和错误率。据说存在差异。 因此，外科医生可能会继续接受这两种技术的培训。 因此，外科医生越来越多地采用 3D 技术有望推动市场增长。

此外，由于肥胖患病率上升和对减肥手术的需求，市场正在增长。 根据世界卫生组织 2021 年 6 月的数据，2020 年有 3900 万五岁以下儿童超重或肥胖。 超重和肥胖曾经被认为只是高收入国家的问题，现在在低收入和中等收入国家变得越来越普遍，尤其是在城市地区。 根据世界肥胖联盟发布的 2022 年 3 月世界肥胖地图集，到 2030 年，全球将有 10 亿人肥胖，其中包括五分之一的女性和七分之一的男性。我预测。 因此，由于肥胖患病率上升和治疗需求增加，预计 3D 腹腔镜成像市场将在预测期内增长。

此外，传统的腹腔镜摄像机仅包含二维 (2D) 系统，虽然高清 (HD) 系统可以改善图形，但它们缺乏深度感知和空间感知。 通过克服立体视觉的丧失，3D 系统可以改进腹腔镜训练，这可能对市场增长产生积极影响。 例如，2020 年 1 月，Karl Storz SE & Co.KG 推出了带有模块化相机平台的新型 3D 手术成像系统。 这个新系统可以更好地可视化不同手术区域的显微手术和开放式干预。

因此，上述所有因素都有望在预测期内推动市场增长。 然而，与产品相关的高成本限制了市场增长。

3D腹腔镜成像市场趋势

预计在预测期内，减肥手术将占据重要的应用市场份额

随着减肥手术数量的增加，市场有望继续增长。 3D 腹腔镜成像系统的适用性将在减肥手术中得到扩展，因为外科医生需要在手术前对解剖结构进行立体观察以进行准确的解剖。

根据世界卫生组织 2021 年 6 月发布的一份报告，据说世界上五分之一的儿童和青少年超重。 在过去的几十年里，肥胖的发病率急剧上升，现在被认为是一种全球流行病，尤其是在发达国家，那里的生活方式疾病如焦虑、压力、吸烟和饮酒很普遍。我有。 此外，“印度的减肥和代谢手术：我们的立场是什么？ 此外，同样的数据表明，全世界有超过 19 亿成年人超重，6.5 亿人肥胖。 因此，肥胖的高负担和全球减肥手术数量的增加预计将推动对 3D 腹腔镜图像的需求，从而促进该领域的增长。

肥胖还与过早死亡率显着增加、生活质量差和医疗费用高昂有关。 常见的合併症包括高血压、2 型糖尿病、血脂异常、心肌梗塞、某些癌症、中风、睡眠呼吸暂停和骨关节炎。 许多合併症也是导致死亡的主要原因。

因此，提高减肥手术技术的安全性将推动该细分市场的增长。

北美在市场上占据主导地位，预计在预测期内将继续如此。

在预测期内，北美主导着 3D 腹腔镜成像市场。 这是由于越来越多的人倾向于腹腔镜手术而不是开腹手术，以及人们越来越意识到微创手术的好处。 此外，主要参与者之间的产品创新竞争也会影响市场。

此外，对微创 3D 腹腔镜设备不断增长的需求正在推动市场发展。 微创手术方法因其创伤小而被广泛使用。 例如，2020 年 12 月，奥林巴斯宣布为其用于微创手术的 VISERA ELITE II 手术成像平台增加 3D 和红外功能。 添加这样的平台可以帮助医院和运营中心提高效率并降低成本。 应用于妇科、普通外科、骨科、泌尿外科、耳鼻喉科等各个领域。 此外，一些国家的健康保险公司支付微创腹腔镜手术费用。 根据 2022 年 3 月的 Medicare Benefits Schedule，高达 75% 的腹腔镜手术现在由 Medicare (MBS) 承保。 因此，患者对微创手术的偏好正在增加。

此外，该地区的肥胖流行病有望提振市场。 2020 年 9 月 美国疾病控制与预防中心 (CDC) 2022 年 5 月 美国的肥胖患病率已从 30.5% 上升至 41.9%。 严重肥胖的患病率从 4.7% 上升到 9.2%。 此外，根据 2021 年 6 月发布的美国国家健康统计报告，在 20 岁及以上的成年人中，肥胖患病率为 41.9%，严重肥胖为 9.2%，糖尿病为 14.8%。 预计人口中肥胖患病率的增加将推动美国的减肥手术市场。 因此，肥胖患病率的增加和治疗费用的增加预计将推动市场增长。

预计主要市场参与者推出技术先进的产品将在预测期内推动市场增长。 2020 年 12 月，奥林巴斯公司发布了其刚性 3D ENDOEYE 视频腹腔镜的升级版，与传统的 3D 腹腔镜相比，它为外科医生提供了更好的控制。 这一升级为外科医生提供了真正的水平方向。

因此，减肥和泌尿外科手术对 3D 腹腔镜成像的需求不断增长，预计将推动该地区的市场增长。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对 3D 成像技术的偏好和进步
    • 肥胖症的增加和对减肥手术的需求
    • 对微创手术的需求不断增长
  • 市场製约因素
    • 与产品相关的高成本
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 通过申请
    • 妇科手术
    • 减肥手术
    • 泌尿外科
    • 其他应用
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Olympus Corporation
    • Sometech Inc.
    • Karl Storz SE & Co. KG
    • B. Braun Melsungen AG
    • Conmed Corporation
    • Medtronic Plc
    • Siemens Healthineers
    • Stryker Corporation
    • Johnson & Johnson Medical Devices
    • Richard Wolf GmbH
    • Xion Medical
    • Pentax Medical
    • Fujifilm Healthcare

第7章 市场机会今后动向

简介目录
Product Code: 67242

The 3D laparoscopy imaging market is expected to register a CAGR of nearly 4.5% over the forecast period (2022-2027).

With the outbreak of COVID-19, 3D laparoscopy procedures have seen renewed focus as studies have shown that patients who had undergone bariatric surgeries had a lower risk of hospital and intensive care unit (ICU) admissions. According to the study titled "Association of prior metabolic and bariatric surgery with the severity of coronavirus disease (COVID-19) in patients with obesity" published in the Surgery for Obesity and Related Diseases in January 2021, researchers at the Cleveland Clinic commissioned a study and they came up with the above observation that patients with severe obesity who have histories of metabolic surgery have SARS-CoV-2 infections that are less severe, as shown by lower risks of hospital and ICU admission. This is likely to increase the demand for bariatric procedures, which will eventually positively affect the demand for 3D laparoscopy devices. Moreover, according to the study titled "Laparoscopic Gastrointestinal Surgery During COVID-19 Pandemic: Single-Center Experience" by Bhavin Patel in April 2021, laparoscopic procedures have decreased as a result of the COVID-19 era, making it a risky procedure due to a potential risk of viral transmission. Therefore, a decline in laparoscopic surgery could hinder the laparoscopy imaging market. Consequently, the market was significantly impacted during COVID-19.

The factors driving market growth include increasing preference for and advancements in 3D imaging technology, increase in obesity and rising demand for bariatric surgeries, and rising demand for minimally invasive procedures.

According to the study titled "Must Clinics Replace 2D by 3D Environments for an Efficient Training of Laparoscopic Novices? A Critical Analysis of the Learning Curve for Basic Skills" published in the Frontier in Surgery in January 2022, in a straightforward standardized test, laparoscopic novices showed a significant difference between 2D and 3D technology in performance time and error rate. Thus, surgeons may continue to receive training in both methods in the future. Thus, the growing adoption of 3D technology by the surgeon is anticipated to drive the growth of the market.

In addition, the market is growing as a result of the rising prevalence of obesity and the demand for bariatric surgery. According to the World Health Organization in June 2021, there were 39 million under-five years old kids who were overweight or obese in 2020.Overweight and obesity, once thought to be a problem only in high-income nations are now becoming more prevalent in low- and middle-income nations as well, especially in urban areas. Moreover, World Obesity Atlas March 2022 published by the World Obesity Federation, predicts that by 2030, one billion people worldwide, including one in five women and one in seven men, will have obesity. As a result, the market for 3D laparoscopy imaging market is anticipated to grow over the projection period due to the rising prevalence of obesity and the increased need for the procedure.

In addition, a conventional laparoscopic camera consists of only a 2-Dimensional (2D) system and although there is an improvement in graphics from a high definition (HD) system, there is still a lack of depth and spatial perception. 3-Dimensional (3D) systems can potentially improve laparoscopic training by eliminating the need to overcome the loss of stereoscopic vision likely to affect market growth positively. For instance, in January 2020, Karl Storz SE & Co. KG launched a new 3D surgical imaging system with a modular camera platform. The new system allows for better visualization of microsurgical and open interventions in different surgical fields.

Thus, all aforementioned factors are anticipated to boost the market growth over the forecast period. However, the high costs associated with the products restrain the market growth.

3D Laparoscopy Imaging Market Trends

Bariatric Surgery is Expected to Hold Significant Market Share by Application Over the Forecast Period

Due to the increasing number of bariatric surgeries performed, the market will continue to grow. The application scope of 3D laparoscopy imaging systems is likely to expand in bariatric surgeries, as surgeons require a stereoscopic vision of anatomy for an accurate dissection prior to surgery.

According to the World Health Organization's report published in June 2021, One in five children and adolescents globally are overweight. Incidences of obesity have been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Furthermore, as per the study titled "Bariatric and Metabolic Surgery in India: Where Do We Stand?" published in the Indian Journal of Surgery in January 2022, a total of 833,687 bariatric procedures were performed around the world in 2020. in addition as per the same source, Over 1.9 billion adults worldwide are overweight, with 650 million being obese. Thus, the high burden of obesity and rising in the number of bariatric surgery performed across globe anticipated to drive the demand of 3D laparoscopy imaging thereby boost the segment growth.

Obesity is also associated with substantial increases in premature mortality, impaired quality of life, and substantial costs of healthcare. The major comorbidities include hypertension, Type-2 diabetes, dyslipidaemia, myocardial infarction, certain cancers, stroke, sleep apnea, and osteoarthritis. Most of the comorbidities are the leading causes of death too.

Thus, increase the safety of the bariatric surgical techniques, driving the growth of the segment in the market.

North America Dominates the Market and is expected to continue so Over the Forecast Period

North America dominates the 3D laparoscopic imaging market over the forecast period. This can be attributed to a growing preference for laparoscopic surgery over open surgery, as well as increased awareness of the advantages of minimally invasive procedures. Furthermore, product innovation competition among major players will have an impact on the market.

Furthermore, the market is being propelled forward by a growing demand for minimally invasive 3D laparoscopic equipment. Because of the less trauma they cause, minimally invasive surgical methods are becoming more popular. For example, in December 2020, Olympus reported that their VISERA ELITE II surgical imaging platform for minimally invasive surgery will now include 3D and infrared capabilities. The addition of a platform like this could aid hospitals and operation centers in increasing efficiency and lowering costs. Gynecology, general surgery, orthopedic surgery, endourology, and ENT are just a few of the applications for the product. Furthermore, health insurance companies in some countries pay for minimally invasive laparoscopic surgeries. According to the Medicare Benefits Schedule march 2022, up to 75% of laparoscopic procedures are now covered by Medicare (MBS). As a result of these considerations, patients' preferences for minimally invasive surgeries have increased.

Moreover, increasing prevalence of obesity in the region anticipated to boost the market. In September 2020, the Centers for Disease Control and Prevention (CDC) May 2022, the prevalence of obesity in the United States increased from 30.5 to 41.9%. The prevalence of severe obesity rose from 4.7 percent to 9.2%. Moreover, As per United States National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States.Thus, increasing prevalence of the obesity and rising in spending of its treatment anticipated to boost the market growth.

Launch of technological advanced productby the key market players expected to grow the market over the forecast period. In December 2020, Olympus Corporation released an upgraded version of its rigid 3D ENDOEYE video laparoscope, which allows surgeons greater control than conventional 3D laparoscopes. The upgrade provides true horizon orientation for surgeons.

Hence, the rising demand for 3D laparoscopic imaging for bariatric and urologic surgeries is expected to propel the market growth in the region.

3D Laparoscopy Imaging Market Competitor Analysis

The global 3D laparoscopy imaging market is moderately competitive and consists of a few major players. Companies like Olympus Corporation, Sometech, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, Fujifilm Healthcare, Medtronic, and Siemens Healthineers, among others, hold the substantial market share in the 3D laparoscopy imaging market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for and Advancements of 3D Imaging Technology
    • 4.2.2 Rise in Obesity and Increase in Demand for Bariatric Surgeries
    • 4.2.3 Rising Demand for Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Products
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Application
    • 5.1.1 Gynecological Surgery
    • 5.1.2 Bariatric Surgery
    • 5.1.3 Urological Surgery
    • 5.1.4 Other Applications
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Olympus Corporation
    • 6.1.2 Sometech Inc.
    • 6.1.3 Karl Storz SE & Co. KG
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Conmed Corporation
    • 6.1.6 Medtronic Plc
    • 6.1.7 Siemens Healthineers
    • 6.1.8 Stryker Corporation
    • 6.1.9 Johnson & Johnson Medical Devices
    • 6.1.10 Richard Wolf GmbH
    • 6.1.11 Xion Medical
    • 6.1.12 Pentax Medical
    • 6.1.13 Fujifilm Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS